Authors: RUDNICKI S LANDEL J KATZ M HABBOUSHE D ROSS RD FAUST L

Citation: S. Rudnicki et al., IDENTIFYING RISK-FACTORS FOR DEPRESSIVE STATES DURING PREGNANCY IN MINORITY WOMEN, Journal of women's health, 7(5), 1998, pp. 633-633

Authors: KIRSE DJ STERN SJ SUEN JY RUDNICKI S ROBERSON PK SCHAEFER RF

Citation: Dj. Kirse et al., NEUROTOXIC EFFECTS OF DOXYCYCLINE SCLEROTHERAPY, Otolaryngology and head and neck surgery, 118(3), 1998, pp. 356-362

Authors: JAIN P SCHMIDLEY JW MRAK RE RUDNICKI S

Citation: P. Jain et al., CLINICALLY DIAGNOSED NON-WILSONIAN HEPATOCEREBRAL DEGENERATION, Brain pathology, 6(3), 1996, pp. 352-352

Authors: LANGE DJ FELICE KJ FESTOFF BW GAWEL MJ GELINAS DF KRATZ R LAI EC MURPHY MF NATTER HM NORRIS FH RUDNICKI S

Citation: Dj. Lange et al., RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR-I IN ALS - DESCRIPTION OF A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Neurology, 47(4), 1996, pp. 93-94

Authors: RUDNICKI S

Citation: S. Rudnicki, RESIDENT CONTINUITY CLINIC - THE SEEN AND UNSEEN, Neurology, 46(2), 1996, pp. 17005-17005

Authors: MURPHY MF FELICE K GAWEL M GELINAS D KRATZ R LAI E LANGE D NATTER H RUDNICKI S

Citation: Mf. Murphy et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MYOTROPHIN (CEP-151) IN THE TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS, Annals of neurology, 38(2), 1995, pp. 335-335